Nicole Rusaw-George
Financieel Directeur/CFO bij LIMINAL BIOSCIENCES INC.
Actieve functies van Nicole Rusaw-George
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
LIMINAL BIOSCIENCES INC. | Financieel Directeur/CFO | 02-03-2022 | - |
Loopbaan van Nicole Rusaw-George
Eerdere bekende functies van Nicole Rusaw-George
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
COPLAND ROAD CAPITAL CORPORATION | Financieel Directeur/CFO | 01-10-2019 | 09-06-2022 |
IONIC BRANDS CORP. | Financieel Directeur/CFO | 01-06-2021 | 13-12-2021 |
NUVO PHARMACEUTICALS INC. | Financieel Directeur/CFO | 01-08-2017 | - |
NEUPATH HEALTH INC. | Directeur/Bestuurslid | 01-04-2019 | - |
Financieel Directeur/CFO | 01-04-2019 | - | |
Bedrijfssecretaris | - | - | |
TRANSITION THERAPEUTICS INC | Financieel Directeur/CFO | 13-12-2011 | - |
Corporate Officer/Principal | 04-07-2008 | 13-12-2011 |
Opleiding van Nicole Rusaw-George
Brock University | Undergraduate Degree |
Statistieken
Internationaal
Canada | 7 |
Verenigde Staten | 2 |
Operationeel
Director of Finance/CFO | 6 |
Corporate Officer/Principal | 1 |
Undergraduate Degree | 1 |
Sectoraal
Health Technology | 4 |
Consumer Services | 2 |
Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
COPLAND ROAD CAPITAL CORPORATION | Process Industries |
IONIC BRANDS CORP. | Producer Manufacturing |
LIMINAL BIOSCIENCES INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Transition Therapeutics, Inc.
Transition Therapeutics, Inc. Medical SpecialtiesHealth Technology Transition Therapeutics, Inc. develops novel therapeutics for disease indications. It operates through research and development of therapeutic agents segment. The firm's products include ELND005 for the treatment of alzheimer's disease, bipolar disorder and down syndrome. Its metabolic drug candidate is TT401 for treatment of type 2 diabetes and accompanying obesity. Transition Therapeutics was founded by Tony F. Cruz on July 6, 1998 and is headquartered in Toronto, Canada. | Health Technology |
Nuvo Pharmaceuticals, Inc.
Nuvo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nuvo Pharmaceuticals, Inc. is a pharmaceutical company, which is engaged in developing innovative therapeutic pharmaceutical products. It operates through the following segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. The Commercial Business segment includes Blexten, Cambia, the canadian business for Resultz and Suvexx, and mature assets. The Production and Service Business segment supplies Pennsaid to Horizon for the U.S. market and is engaged in ongoing partnering efforts for Pennsaid. The Licensing and Royalty Business segment engages in the selling of Vimovo. The company was founded on August 22, 1983 and is headquartered in Mississauga, Canada. | Health Technology |
Klinik Health Ventures Corp.
Klinik Health Ventures Corp. Financial ConglomeratesFinance Klinik Health Ventures Corp. operates as a capital pool company. The company was founded on April 17, 2019 and is headquartered in Toronto, Canada. | Finance |
- Beurs
- Insiders
- Nicole Rusaw-George
- Ervaring